Login to Your Account


Despite Short-Term Revenue Hit, Sanofi Manages Patent Cliff

By Marie Powers
Staff Writer

Friday, October 26, 2012
Sanofi SA, which reported third-quarter results Thursday, placed its pipeline challenges front and center, noting "business [earnings per share] reflects patent expirations."

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription